aluates Reports

$ 0.0

Automative

Global Living Biological Drugs Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-1W12142

Global Living Biological Drugs Market Research Report 2022

BUY CHAPTERS

Global Living Biological Drugs Market Research Report 2024

Code: QYRE-Auto-1W12142

Report

April 2024

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Miyarisan Pharmaceutical

Ferring Pharmaceuticals

Seres Therapeutics

Osel

Takeda

AOBiome

Synlogic

Capsugel

Jeneil Biotech

UAS Labs

Biose

Cerbios-Pharma

Inpac Probiotics

NIZO

Winclove Probiotics

BJP Laboratories

MATRISYS BIOSCIENCE

Ardeypharman

Infant Bacterial Therapeutics

Finch Therapeutics

Luina Bio

List Labs

Living Biological Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Living Biological Drugs Market

The global Living Biological Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Living Biological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Living Biological Drugs.

Report Scope

The Living Biological Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Living Biological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Living Biological Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Living Biological Drugs Market Report

Report Metric	Details
Report Name	Living Biological Drugs Market
CAGR	5%
Segment by Type	Single Strain Multi Strain Co-Culture
Segment by Application	Digestive System Urinary System Skin System
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ardeypharman, Miyarisan Pharmaceutical, Ferring Pharmaceuticals, Seres Therapeutics, Infant Bacterial Therapeutics, Osel, Takeda, AOBiome, Synlogic, Finch Therapeutics, Capsugel, Jeneil Biotech, UAS Labs, Biose, Cerbios-Pharma, Inpac Probiotics, NIZO, Winclove Probiotics, BJP Laboratories, Luina Bio, List Labs, MatriSys Bioscience
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Living Biological Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Living Biological Drugs Market report?

Ans: The main players in the Living Biological Drugs Market are Ardeypharman, Miyarisan Pharmaceutical, Ferring Pharmaceuticals, Seres Therapeutics, Infant Bacterial Therapeutics, Osel, Takeda, AOBiome, Synlogic, Finch Therapeutics, Capsugel, Jeneil Biotech, UAS Labs, Biose, Cerbios-Pharma, Inpac Probiotics, NIZO, Winclove Probiotics, BJP Laboratories, Luina Bio, List Labs, MatriSys Bioscience

What are the Application segmentation covered in the Living Biological Drugs Market report?

Ans: The Applications covered in the Living Biological Drugs Market report are Digestive System, Urinary System, Skin System

What are the Type segmentation covered in the Living Biological Drugs Market report?

Ans: The Types covered in the Living Biological Drugs Market report are Single Strain, Multi Strain, Co-Culture

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Living Biological Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Single Strain

1.2.3 Multi Strain

1.2.4 Co-Culture

1.3 Market by Application

1.3.1 Global Living Biological Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Digestive System

1.3.3 Urinary System

1.3.4 Skin System

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Living Biological Drugs Market Perspective (2019-2030)

2.2 Living Biological Drugs Growth Trends by Region

2.2.1 Global Living Biological Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Living Biological Drugs Historic Market Size by Region (2019-2024)

2.2.3 Living Biological Drugs Forecasted Market Size by Region (2025-2030)

2.3 Living Biological Drugs Market Dynamics

2.3.1 Living Biological Drugs Industry Trends

2.3.2 Living Biological Drugs Market Drivers

2.3.3 Living Biological Drugs Market Challenges

2.3.4 Living Biological Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Living Biological Drugs Players by Revenue

3.1.1 Global Top Living Biological Drugs Players by Revenue (2019-2024)

3.1.2 Global Living Biological Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Living Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Living Biological Drugs Revenue

3.4 Global Living Biological Drugs Market Concentration Ratio

3.4.1 Global Living Biological Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Living Biological Drugs Revenue in 2023

3.5 Living Biological Drugs Key Players Head office and Area Served

3.6 Key Players Living Biological Drugs Product Solution and Service

3.7 Date of Enter into Living Biological Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Living Biological Drugs Breakdown Data by Type

4.1 Global Living Biological Drugs Historic Market Size by Type (2019-2024)

4.2 Global Living Biological Drugs Forecasted Market Size by Type (2025-2030)

5 Living Biological Drugs Breakdown Data by Application

5.1 Global Living Biological Drugs Historic Market Size by Application (2019-2024)

5.2 Global Living Biological Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Living Biological Drugs Market Size (2019-2030)

6.2 North America Living Biological Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Living Biological Drugs Market Size by Country (2019-2024)

6.4 North America Living Biological Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Living Biological Drugs Market Size (2019-2030)

7.2 Europe Living Biological Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Living Biological Drugs Market Size by Country (2019-2024)

7.4 Europe Living Biological Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Living Biological Drugs Market Size (2019-2030)

8.2 Asia-Pacific Living Biological Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Living Biological Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Living Biological Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Living Biological Drugs Market Size (2019-2030)

9.2 Latin America Living Biological Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Living Biological Drugs Market Size by Country (2019-2024)

9.4 Latin America Living Biological Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Living Biological Drugs Market Size (2019-2030)

10.2 Middle East & Africa Living Biological Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Living Biological Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Living Biological Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ardeypharman

11.1.1 Ardeypharman Company Detail

11.1.2 Ardeypharman Business Overview

11.1.3 Ardeypharman Living Biological Drugs Introduction

11.1.4 Ardeypharman Revenue in Living Biological Drugs Business (2019-2024)

11.1.5 Ardeypharman Recent Development

11.2 Miyarisan Pharmaceutical

11.2.1 Miyarisan Pharmaceutical Company Detail

11.2.2 Miyarisan Pharmaceutical Business Overview

11.2.3 Miyarisan Pharmaceutical Living Biological Drugs Introduction

11.2.4 Miyarisan Pharmaceutical Revenue in Living Biological Drugs Business (2019-2024)

11.2.5 Miyarisan Pharmaceutical Recent Development

11.3 Ferring Pharmaceuticals

11.3.1 Ferring Pharmaceuticals Company Detail

11.3.2 Ferring Pharmaceuticals Business Overview

11.3.3 Ferring Pharmaceuticals Living Biological Drugs Introduction

11.3.4 Ferring Pharmaceuticals Revenue in Living Biological Drugs Business (2019-2024)

11.3.5 Ferring Pharmaceuticals Recent Development

11.4 Seres Therapeutics

11.4.1 Seres Therapeutics Company Detail

11.4.2 Seres Therapeutics Business Overview

11.4.3 Seres Therapeutics Living Biological Drugs Introduction

11.4.4 Seres Therapeutics Revenue in Living Biological Drugs Business (2019-2024)

11.4.5 Seres Therapeutics Recent Development

11.5 Infant Bacterial Therapeutics

11.5.1 Infant Bacterial Therapeutics Company Detail

11.5.2 Infant Bacterial Therapeutics Business Overview

11.5.3 Infant Bacterial Therapeutics Living Biological Drugs Introduction

11.5.4 Infant Bacterial Therapeutics Revenue in Living Biological Drugs Business (2019-2024)

11.5.5 Infant Bacterial Therapeutics Recent Development

11.6 Osel

11.6.1 Osel Company Detail

11.6.2 Osel Business Overview

11.6.3 Osel Living Biological Drugs Introduction

11.6.4 Osel Revenue in Living Biological Drugs Business (2019-2024)

11.6.5 Osel Recent Development

11.7 Takeda

11.7.1 Takeda Company Detail

11.7.2 Takeda Business Overview

11.7.3 Takeda Living Biological Drugs Introduction

11.7.4 Takeda Revenue in Living Biological Drugs Business (2019-2024)

11.7.5 Takeda Recent Development

11.8 AOBiome

11.8.1 AOBiome Company Detail

11.8.2 AOBiome Business Overview

11.8.3 AOBiome Living Biological Drugs Introduction

11.8.4 AOBiome Revenue in Living Biological Drugs Business (2019-2024)

11.8.5 AOBiome Recent Development

11.9 Synlogic

11.9.1 Synlogic Company Detail

11.9.2 Synlogic Business Overview

11.9.3 Synlogic Living Biological Drugs Introduction

11.9.4 Synlogic Revenue in Living Biological Drugs Business (2019-2024)

11.9.5 Synlogic Recent Development

11.10 Finch Therapeutics

11.10.1 Finch Therapeutics Company Detail

11.10.2 Finch Therapeutics Business Overview

11.10.3 Finch Therapeutics Living Biological Drugs Introduction

11.10.4 Finch Therapeutics Revenue in Living Biological Drugs Business (2019-2024)

11.10.5 Finch Therapeutics Recent Development

11.11 Capsugel

11.11.1 Capsugel Company Detail

11.11.2 Capsugel Business Overview

11.11.3 Capsugel Living Biological Drugs Introduction

11.11.4 Capsugel Revenue in Living Biological Drugs Business (2019-2024)

11.11.5 Capsugel Recent Development

11.12 Jeneil Biotech

11.12.1 Jeneil Biotech Company Detail

11.12.2 Jeneil Biotech Business Overview

11.12.3 Jeneil Biotech Living Biological Drugs Introduction

11.12.4 Jeneil Biotech Revenue in Living Biological Drugs Business (2019-2024)

11.12.5 Jeneil Biotech Recent Development

11.13 UAS Labs

11.13.1 UAS Labs Company Detail

11.13.2 UAS Labs Business Overview

11.13.3 UAS Labs Living Biological Drugs Introduction

11.13.4 UAS Labs Revenue in Living Biological Drugs Business (2019-2024)

11.13.5 UAS Labs Recent Development

11.14 Biose

11.14.1 Biose Company Detail

11.14.2 Biose Business Overview

11.14.3 Biose Living Biological Drugs Introduction

11.14.4 Biose Revenue in Living Biological Drugs Business (2019-2024)

11.14.5 Biose Recent Development

11.15 Cerbios-Pharma

11.15.1 Cerbios-Pharma Company Detail

11.15.2 Cerbios-Pharma Business Overview

11.15.3 Cerbios-Pharma Living Biological Drugs Introduction

11.15.4 Cerbios-Pharma Revenue in Living Biological Drugs Business (2019-2024)

11.15.5 Cerbios-Pharma Recent Development

11.16 Inpac Probiotics

11.16.1 Inpac Probiotics Company Detail

11.16.2 Inpac Probiotics Business Overview

11.16.3 Inpac Probiotics Living Biological Drugs Introduction

11.16.4 Inpac Probiotics Revenue in Living Biological Drugs Business (2019-2024)

11.16.5 Inpac Probiotics Recent Development

11.17 NIZO

11.17.1 NIZO Company Detail

11.17.2 NIZO Business Overview

11.17.3 NIZO Living Biological Drugs Introduction

11.17.4 NIZO Revenue in Living Biological Drugs Business (2019-2024)

11.17.5 NIZO Recent Development

11.18 Winclove Probiotics

11.18.1 Winclove Probiotics Company Detail

11.18.2 Winclove Probiotics Business Overview

11.18.3 Winclove Probiotics Living Biological Drugs Introduction

11.18.4 Winclove Probiotics Revenue in Living Biological Drugs Business (2019-2024)

11.18.5 Winclove Probiotics Recent Development

11.19 BJP Laboratories

11.19.1 BJP Laboratories Company Detail

11.19.2 BJP Laboratories Business Overview

11.19.3 BJP Laboratories Living Biological Drugs Introduction

11.19.4 BJP Laboratories Revenue in Living Biological Drugs Business (2019-2024)

11.19.5 BJP Laboratories Recent Development

11.20 Luina Bio

11.20.1 Luina Bio Company Detail

11.20.2 Luina Bio Business Overview

11.20.3 Luina Bio Living Biological Drugs Introduction

11.20.4 Luina Bio Revenue in Living Biological Drugs Business (2019-2024)

11.20.5 Luina Bio Recent Development

11.21 List Labs

11.21.1 List Labs Company Detail

11.21.2 List Labs Business Overview

11.21.3 List Labs Living Biological Drugs Introduction

11.21.4 List Labs Revenue in Living Biological Drugs Business (2019-2024)

11.21.5 List Labs Recent Development

11.22 MatriSys Bioscience

11.22.1 MatriSys Bioscience Company Detail

11.22.2 MatriSys Bioscience Business Overview

11.22.3 MatriSys Bioscience Living Biological Drugs Introduction

11.22.4 MatriSys Bioscience Revenue in Living Biological Drugs Business (2019-2024)

11.22.5 MatriSys Bioscience Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Miyarisan Pharmaceutical

Ferring Pharmaceuticals

Seres Therapeutics

Osel

Takeda

AOBiome

Synlogic

Capsugel

Jeneil Biotech

UAS Labs

Biose

Cerbios-Pharma

Inpac Probiotics

NIZO

Winclove Probiotics

BJP Laboratories

MATRISYS BIOSCIENCE

Ardeypharman

Infant Bacterial Therapeutics

Finch Therapeutics

Luina Bio

List Labs

List of Tables

Table 1. Global Living Biological Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Single Strain

Table 3. Key Players of Multi Strain

Table 4. Key Players of Co-Culture

Table 5. Global Living Biological Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Living Biological Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Living Biological Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Living Biological Drugs Market Share by Region (2019-2024)

Table 9. Global Living Biological Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Living Biological Drugs Market Share by Region (2025-2030)

Table 11. Living Biological Drugs Market Trends

Table 12. Living Biological Drugs Market Drivers

Table 13. Living Biological Drugs Market Challenges

Table 14. Living Biological Drugs Market Restraints

Table 15. Global Living Biological Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Living Biological Drugs Market Share by Players (2019-2024)

Table 17. Global Top Living Biological Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Living Biological Drugs as of 2023)

Table 18. Ranking of Global Top Living Biological Drugs Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Living Biological Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Living Biological Drugs Product Solution and Service

Table 22. Date of Enter into Living Biological Drugs Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Living Biological Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Living Biological Drugs Revenue Market Share by Type (2019-2024)

Table 26. Global Living Biological Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Living Biological Drugs Revenue Market Share by Type (2025-2030)

Table 28. Global Living Biological Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Living Biological Drugs Revenue Market Share by Application (2019-2024)

Table 30. Global Living Biological Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Living Biological Drugs Revenue Market Share by Application (2025-2030)

Table 32. North America Living Biological Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Living Biological Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Living Biological Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Living Biological Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Living Biological Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Living Biological Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Living Biological Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Living Biological Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Living Biological Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Living Biological Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Living Biological Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Living Biological Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Living Biological Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Living Biological Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Living Biological Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. Ardeypharman Company Detail

Table 48. Ardeypharman Business Overview

Table 49. Ardeypharman Living Biological Drugs Product

Table 50. Ardeypharman Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 51. Ardeypharman Recent Development

Table 52. Miyarisan Pharmaceutical Company Detail

Table 53. Miyarisan Pharmaceutical Business Overview

Table 54. Miyarisan Pharmaceutical Living Biological Drugs Product

Table 55. Miyarisan Pharmaceutical Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 56. Miyarisan Pharmaceutical Recent Development

Table 57. Ferring Pharmaceuticals Company Detail

Table 58. Ferring Pharmaceuticals Business Overview

Table 59. Ferring Pharmaceuticals Living Biological Drugs Product

Table 60. Ferring Pharmaceuticals Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 61. Ferring Pharmaceuticals Recent Development

Table 62. Seres Therapeutics Company Detail

Table 63. Seres Therapeutics Business Overview

Table 64. Seres Therapeutics Living Biological Drugs Product

Table 65. Seres Therapeutics Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 66. Seres Therapeutics Recent Development

Table 67. Infant Bacterial Therapeutics Company Detail

Table 68. Infant Bacterial Therapeutics Business Overview

Table 69. Infant Bacterial Therapeutics Living Biological Drugs Product

Table 70. Infant Bacterial Therapeutics Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 71. Infant Bacterial Therapeutics Recent Development

Table 72. Osel Company Detail

Table 73. Osel Business Overview

Table 74. Osel Living Biological Drugs Product

Table 75. Osel Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 76. Osel Recent Development

Table 77. Takeda Company Detail

Table 78. Takeda Business Overview

Table 79. Takeda Living Biological Drugs Product

Table 80. Takeda Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 81. Takeda Recent Development

Table 82. AOBiome Company Detail

Table 83. AOBiome Business Overview

Table 84. AOBiome Living Biological Drugs Product

Table 85. AOBiome Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 86. AOBiome Recent Development

Table 87. Synlogic Company Detail

Table 88. Synlogic Business Overview

Table 89. Synlogic Living Biological Drugs Product

Table 90. Synlogic Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 91. Synlogic Recent Development

Table 92. Finch Therapeutics Company Detail

Table 93. Finch Therapeutics Business Overview

Table 94. Finch Therapeutics Living Biological Drugs Product

Table 95. Finch Therapeutics Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 96. Finch Therapeutics Recent Development

Table 97. Capsugel Company Detail

Table 98. Capsugel Business Overview

Table 99. Capsugel Living Biological Drugs Product

Table 100. Capsugel Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 101. Capsugel Recent Development

Table 102. Jeneil Biotech Company Detail

Table 103. Jeneil Biotech Business Overview

Table 104. Jeneil Biotech Living Biological Drugs Product

Table 105. Jeneil Biotech Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 106. Jeneil Biotech Recent Development

Table 107. UAS Labs Company Detail

Table 108. UAS Labs Business Overview

Table 109. UAS Labs Living Biological Drugs Product

Table 110. UAS Labs Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 111. UAS Labs Recent Development

Table 112. Biose Company Detail

Table 113. Biose Business Overview

Table 114. Biose Living Biological Drugs Product

Table 115. Biose Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 116. Biose Recent Development

Table 117. Cerbios-Pharma Company Detail

Table 118. Cerbios-Pharma Business Overview

Table 119. Cerbios-Pharma Living Biological Drugs Product

Table 120. Cerbios-Pharma Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 121. Cerbios-Pharma Recent Development

Table 122. Inpac Probiotics Company Detail

Table 123. Inpac Probiotics Business Overview

Table 124. Inpac Probiotics Living Biological Drugs Product

Table 125. Inpac Probiotics Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 126. Inpac Probiotics Recent Development

Table 127. NIZO Company Detail

Table 128. NIZO Business Overview

Table 129. NIZO Living Biological Drugs Product

Table 130. NIZO Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 131. NIZO Recent Development

Table 132. Winclove Probiotics Company Detail

Table 133. Winclove Probiotics Business Overview

Table 134. Winclove Probiotics Living Biological Drugs Product

Table 135. Winclove Probiotics Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 136. Winclove Probiotics Recent Development

Table 137. BJP Laboratories Company Detail

Table 138. BJP Laboratories Business Overview

Table 139. BJP Laboratories Living Biological Drugs Product

Table 140. BJP Laboratories Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 141. BJP Laboratories Recent Development

Table 142. Luina Bio Company Detail

Table 143. Luina Bio Business Overview

Table 144. Luina Bio Living Biological Drugs Product

Table 145. Luina Bio Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 146. Luina Bio Recent Development

Table 147. List Labs Company Detail

Table 148. List Labs Business Overview

Table 149. List Labs Living Biological Drugs Product

Table 150. List Labs Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 151. List Labs Recent Development

Table 152. MatriSys Bioscience Company Detail

Table 153. MatriSys Bioscience Business Overview

Table 154. MatriSys Bioscience Living Biological Drugs Product

Table 155. MatriSys Bioscience Revenue in Living Biological Drugs Business (2019-2024) & (US$ Million)

Table 156. MatriSys Bioscience Recent Development

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Living Biological Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Living Biological Drugs Market Share by Type: 2023 VS 2030

Figure 3. Single Strain Features

Figure 4. Multi Strain Features

Figure 5. Co-Culture Features

Figure 6. Global Living Biological Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Living Biological Drugs Market Share by Application: 2023 VS 2030

Figure 8. Digestive System Case Studies

Figure 9. Urinary System Case Studies

Figure 10. Skin System Case Studies

Figure 11. Living Biological Drugs Report Years Considered

Figure 12. Global Living Biological Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Living Biological Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Living Biological Drugs Market Share by Region: 2023 VS 2030

Figure 15. Global Living Biological Drugs Market Share by Players in 2023

Figure 16. Global Top Living Biological Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Living Biological Drugs as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Living Biological Drugs Revenue in 2023

Figure 18. North America Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Living Biological Drugs Market Share by Country (2019-2030)

Figure 20. United States Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Living Biological Drugs Market Share by Country (2019-2030)

Figure 24. Germany Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Living Biological Drugs Market Share by Region (2019-2030)

Figure 32. China Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Living Biological Drugs Market Share by Country (2019-2030)

Figure 40. Mexico Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Living Biological Drugs Market Share by Country (2019-2030)

Figure 44. Turkey Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Living Biological Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Ardeypharman Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 47. Miyarisan Pharmaceutical Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 48. Ferring Pharmaceuticals Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 49. Seres Therapeutics Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 50. Infant Bacterial Therapeutics Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 51. Osel Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 52. Takeda Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 53. AOBiome Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 54. Synlogic Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 55. Finch Therapeutics Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 56. Capsugel Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 57. Jeneil Biotech Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 58. UAS Labs Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 59. Biose Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 60. Cerbios-Pharma Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 61. Inpac Probiotics Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 62. NIZO Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 63. Winclove Probiotics Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 64. BJP Laboratories Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 65. Luina Bio Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 66. List Labs Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 67. MatriSys Bioscience Revenue Growth Rate in Living Biological Drugs Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stainless Steel Medication Trolley Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18N15820

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Instant Molecular Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G15638

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Universal Cell Therapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U15769

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Preclinical Toxicology Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1P15930

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions